Hindgut and Midgut Neuroendocrine Tumors - Therapeutic Approach

Neuroendocrine tumors of the gastro-entero-pancreatic system have a variety of components, clinical manifestations and prognostic indices according to their anatomical site. Therefore, their diagnostic and management strategies differ a great deal. Prognosis concerning NETs can be poor due to the de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chirurgia (Bucharest, Romania : 1990) Romania : 1990), 2019-03, Vol.114 (2), p.243-250
Hauptverfasser: Gavrilescu, Mihaela Mădălina, Huţanu, Ionuţ, Filip, Bogdan, Anitei, Maria Gabriela, Buna-Arvinte, Mihaela, Muşină, Ana-Maria, Panuta, Adrian, Moraru, Vanda, Radu, Iulian, Scripcariu, Dragoş Viorel, Scripcariu, Viorel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 250
container_issue 2
container_start_page 243
container_title Chirurgia (Bucharest, Romania : 1990)
container_volume 114
creator Gavrilescu, Mihaela Mădălina
Huţanu, Ionuţ
Filip, Bogdan
Anitei, Maria Gabriela
Buna-Arvinte, Mihaela
Muşină, Ana-Maria
Panuta, Adrian
Moraru, Vanda
Radu, Iulian
Scripcariu, Dragoş Viorel
Scripcariu, Viorel
description Neuroendocrine tumors of the gastro-entero-pancreatic system have a variety of components, clinical manifestations and prognostic indices according to their anatomical site. Therefore, their diagnostic and management strategies differ a great deal. Prognosis concerning NETs can be poor due to the degree of differentiation, early metastasizing and the high degree of invasiveness. Material and For the present study, the patient files were evaluated and the parameters of interest were followed. Over the course of 6 years there were 37 patients diagnosed with and treated for NETs, regardless of primary tumor site. There were 9 patients with NETs of the primite mid- and hindgut thusly: 5 cases with colorectal NETs and 4 cases of small bowel NETs. 6 patients benefited from radical surgical treatment, 2 cases with palliative procedures and only one patient with tumor biopsy. The tumors were evaluated according to the 2010 WHO classification based on the number of mitoses and the Ki67 proliferation index. Adjuvant treatment was adapted according to staging and histopathological parameters. Despite recent progress in managing NETs, there are still many controversial aspects regarding the management of these cases, mainly about timing the right sequence of therapy.
doi_str_mv 10.21614/chirurgia.114.2.243
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2232136063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2232136063</sourcerecordid><originalsourceid>FETCH-LOGICAL-c232t-2da06a095fff2ab5594db85277406946565ce61f837d2230cfebd4369f705d403</originalsourceid><addsrcrecordid>eNo9kDtPAzEQhF2ASBTyDxC6kuYOe_24XIWiCAhSgCbUls_2JUa5B_a54N9jJSHb7BQzO9oPoTuCCyCCsEe9dz76nVMFIayAAhi9QlMCQPKKkMUEzUP4xmkEBozpDZpQkrTg5RQ9rV1ndnHMVGeyd3eUHzb63nam1951NtvGtvchy7Pt3no12Dg6nS2HwfdK72_RdaMOwc7Pe4a-Xp63q3W--Xx9Wy03uQYKYw5GYaFwxZumAVVzXjFTLziUJcOiYoILrq0gzYKWBoBi3djaMCqqpsTcMExn6OF0N9X-RBtG2bqg7eGgOtvHIFMICE1P0WRlJ6v2fQjeNnLwrlX-VxIsj8TkhZhMxCTIRCzF7s8NsW6tuYT-WdE_2cRqOA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2232136063</pqid></control><display><type>article</type><title>Hindgut and Midgut Neuroendocrine Tumors - Therapeutic Approach</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Gavrilescu, Mihaela Mădălina ; Huţanu, Ionuţ ; Filip, Bogdan ; Anitei, Maria Gabriela ; Buna-Arvinte, Mihaela ; Muşină, Ana-Maria ; Panuta, Adrian ; Moraru, Vanda ; Radu, Iulian ; Scripcariu, Dragoş Viorel ; Scripcariu, Viorel</creator><creatorcontrib>Gavrilescu, Mihaela Mădălina ; Huţanu, Ionuţ ; Filip, Bogdan ; Anitei, Maria Gabriela ; Buna-Arvinte, Mihaela ; Muşină, Ana-Maria ; Panuta, Adrian ; Moraru, Vanda ; Radu, Iulian ; Scripcariu, Dragoş Viorel ; Scripcariu, Viorel</creatorcontrib><description>Neuroendocrine tumors of the gastro-entero-pancreatic system have a variety of components, clinical manifestations and prognostic indices according to their anatomical site. Therefore, their diagnostic and management strategies differ a great deal. Prognosis concerning NETs can be poor due to the degree of differentiation, early metastasizing and the high degree of invasiveness. Material and For the present study, the patient files were evaluated and the parameters of interest were followed. Over the course of 6 years there were 37 patients diagnosed with and treated for NETs, regardless of primary tumor site. There were 9 patients with NETs of the primite mid- and hindgut thusly: 5 cases with colorectal NETs and 4 cases of small bowel NETs. 6 patients benefited from radical surgical treatment, 2 cases with palliative procedures and only one patient with tumor biopsy. The tumors were evaluated according to the 2010 WHO classification based on the number of mitoses and the Ki67 proliferation index. Adjuvant treatment was adapted according to staging and histopathological parameters. Despite recent progress in managing NETs, there are still many controversial aspects regarding the management of these cases, mainly about timing the right sequence of therapy.</description><identifier>ISSN: 1221-9118</identifier><identifier>DOI: 10.21614/chirurgia.114.2.243</identifier><identifier>PMID: 31060657</identifier><language>eng</language><publisher>Romania</publisher><subject>Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage ; Breast Neoplasms - diagnosis ; Breast Neoplasms - therapy ; Chemotherapy, Adjuvant ; Digestive System Neoplasms - diagnosis ; Digestive System Neoplasms - drug therapy ; Digestive System Neoplasms - surgery ; Digestive System Neoplasms - therapy ; Disease Management ; Female ; Humans ; Male ; Middle Aged ; Neuroendocrine Tumors - diagnosis ; Neuroendocrine Tumors - drug therapy ; Neuroendocrine Tumors - surgery ; Neuroendocrine Tumors - therapy ; Prognosis ; Retroperitoneal Neoplasms - diagnosis ; Retroperitoneal Neoplasms - therapy ; Treatment Outcome ; Uterine Neoplasms - diagnosis ; Uterine Neoplasms - therapy</subject><ispartof>Chirurgia (Bucharest, Romania : 1990), 2019-03, Vol.114 (2), p.243-250</ispartof><rights>Celsius.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31060657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gavrilescu, Mihaela Mădălina</creatorcontrib><creatorcontrib>Huţanu, Ionuţ</creatorcontrib><creatorcontrib>Filip, Bogdan</creatorcontrib><creatorcontrib>Anitei, Maria Gabriela</creatorcontrib><creatorcontrib>Buna-Arvinte, Mihaela</creatorcontrib><creatorcontrib>Muşină, Ana-Maria</creatorcontrib><creatorcontrib>Panuta, Adrian</creatorcontrib><creatorcontrib>Moraru, Vanda</creatorcontrib><creatorcontrib>Radu, Iulian</creatorcontrib><creatorcontrib>Scripcariu, Dragoş Viorel</creatorcontrib><creatorcontrib>Scripcariu, Viorel</creatorcontrib><title>Hindgut and Midgut Neuroendocrine Tumors - Therapeutic Approach</title><title>Chirurgia (Bucharest, Romania : 1990)</title><addtitle>Chirurgia (Bucur)</addtitle><description>Neuroendocrine tumors of the gastro-entero-pancreatic system have a variety of components, clinical manifestations and prognostic indices according to their anatomical site. Therefore, their diagnostic and management strategies differ a great deal. Prognosis concerning NETs can be poor due to the degree of differentiation, early metastasizing and the high degree of invasiveness. Material and For the present study, the patient files were evaluated and the parameters of interest were followed. Over the course of 6 years there were 37 patients diagnosed with and treated for NETs, regardless of primary tumor site. There were 9 patients with NETs of the primite mid- and hindgut thusly: 5 cases with colorectal NETs and 4 cases of small bowel NETs. 6 patients benefited from radical surgical treatment, 2 cases with palliative procedures and only one patient with tumor biopsy. The tumors were evaluated according to the 2010 WHO classification based on the number of mitoses and the Ki67 proliferation index. Adjuvant treatment was adapted according to staging and histopathological parameters. Despite recent progress in managing NETs, there are still many controversial aspects regarding the management of these cases, mainly about timing the right sequence of therapy.</description><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - therapy</subject><subject>Chemotherapy, Adjuvant</subject><subject>Digestive System Neoplasms - diagnosis</subject><subject>Digestive System Neoplasms - drug therapy</subject><subject>Digestive System Neoplasms - surgery</subject><subject>Digestive System Neoplasms - therapy</subject><subject>Disease Management</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neuroendocrine Tumors - diagnosis</subject><subject>Neuroendocrine Tumors - drug therapy</subject><subject>Neuroendocrine Tumors - surgery</subject><subject>Neuroendocrine Tumors - therapy</subject><subject>Prognosis</subject><subject>Retroperitoneal Neoplasms - diagnosis</subject><subject>Retroperitoneal Neoplasms - therapy</subject><subject>Treatment Outcome</subject><subject>Uterine Neoplasms - diagnosis</subject><subject>Uterine Neoplasms - therapy</subject><issn>1221-9118</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPAzEQhF2ASBTyDxC6kuYOe_24XIWiCAhSgCbUls_2JUa5B_a54N9jJSHb7BQzO9oPoTuCCyCCsEe9dz76nVMFIayAAhi9QlMCQPKKkMUEzUP4xmkEBozpDZpQkrTg5RQ9rV1ndnHMVGeyd3eUHzb63nam1951NtvGtvchy7Pt3no12Dg6nS2HwfdK72_RdaMOwc7Pe4a-Xp63q3W--Xx9Wy03uQYKYw5GYaFwxZumAVVzXjFTLziUJcOiYoILrq0gzYKWBoBi3djaMCqqpsTcMExn6OF0N9X-RBtG2bqg7eGgOtvHIFMICE1P0WRlJ6v2fQjeNnLwrlX-VxIsj8TkhZhMxCTIRCzF7s8NsW6tuYT-WdE_2cRqOA</recordid><startdate>20190301</startdate><enddate>20190301</enddate><creator>Gavrilescu, Mihaela Mădălina</creator><creator>Huţanu, Ionuţ</creator><creator>Filip, Bogdan</creator><creator>Anitei, Maria Gabriela</creator><creator>Buna-Arvinte, Mihaela</creator><creator>Muşină, Ana-Maria</creator><creator>Panuta, Adrian</creator><creator>Moraru, Vanda</creator><creator>Radu, Iulian</creator><creator>Scripcariu, Dragoş Viorel</creator><creator>Scripcariu, Viorel</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190301</creationdate><title>Hindgut and Midgut Neuroendocrine Tumors - Therapeutic Approach</title><author>Gavrilescu, Mihaela Mădălina ; Huţanu, Ionuţ ; Filip, Bogdan ; Anitei, Maria Gabriela ; Buna-Arvinte, Mihaela ; Muşină, Ana-Maria ; Panuta, Adrian ; Moraru, Vanda ; Radu, Iulian ; Scripcariu, Dragoş Viorel ; Scripcariu, Viorel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c232t-2da06a095fff2ab5594db85277406946565ce61f837d2230cfebd4369f705d403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - therapy</topic><topic>Chemotherapy, Adjuvant</topic><topic>Digestive System Neoplasms - diagnosis</topic><topic>Digestive System Neoplasms - drug therapy</topic><topic>Digestive System Neoplasms - surgery</topic><topic>Digestive System Neoplasms - therapy</topic><topic>Disease Management</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neuroendocrine Tumors - diagnosis</topic><topic>Neuroendocrine Tumors - drug therapy</topic><topic>Neuroendocrine Tumors - surgery</topic><topic>Neuroendocrine Tumors - therapy</topic><topic>Prognosis</topic><topic>Retroperitoneal Neoplasms - diagnosis</topic><topic>Retroperitoneal Neoplasms - therapy</topic><topic>Treatment Outcome</topic><topic>Uterine Neoplasms - diagnosis</topic><topic>Uterine Neoplasms - therapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Gavrilescu, Mihaela Mădălina</creatorcontrib><creatorcontrib>Huţanu, Ionuţ</creatorcontrib><creatorcontrib>Filip, Bogdan</creatorcontrib><creatorcontrib>Anitei, Maria Gabriela</creatorcontrib><creatorcontrib>Buna-Arvinte, Mihaela</creatorcontrib><creatorcontrib>Muşină, Ana-Maria</creatorcontrib><creatorcontrib>Panuta, Adrian</creatorcontrib><creatorcontrib>Moraru, Vanda</creatorcontrib><creatorcontrib>Radu, Iulian</creatorcontrib><creatorcontrib>Scripcariu, Dragoş Viorel</creatorcontrib><creatorcontrib>Scripcariu, Viorel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chirurgia (Bucharest, Romania : 1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gavrilescu, Mihaela Mădălina</au><au>Huţanu, Ionuţ</au><au>Filip, Bogdan</au><au>Anitei, Maria Gabriela</au><au>Buna-Arvinte, Mihaela</au><au>Muşină, Ana-Maria</au><au>Panuta, Adrian</au><au>Moraru, Vanda</au><au>Radu, Iulian</au><au>Scripcariu, Dragoş Viorel</au><au>Scripcariu, Viorel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hindgut and Midgut Neuroendocrine Tumors - Therapeutic Approach</atitle><jtitle>Chirurgia (Bucharest, Romania : 1990)</jtitle><addtitle>Chirurgia (Bucur)</addtitle><date>2019-03-01</date><risdate>2019</risdate><volume>114</volume><issue>2</issue><spage>243</spage><epage>250</epage><pages>243-250</pages><issn>1221-9118</issn><abstract>Neuroendocrine tumors of the gastro-entero-pancreatic system have a variety of components, clinical manifestations and prognostic indices according to their anatomical site. Therefore, their diagnostic and management strategies differ a great deal. Prognosis concerning NETs can be poor due to the degree of differentiation, early metastasizing and the high degree of invasiveness. Material and For the present study, the patient files were evaluated and the parameters of interest were followed. Over the course of 6 years there were 37 patients diagnosed with and treated for NETs, regardless of primary tumor site. There were 9 patients with NETs of the primite mid- and hindgut thusly: 5 cases with colorectal NETs and 4 cases of small bowel NETs. 6 patients benefited from radical surgical treatment, 2 cases with palliative procedures and only one patient with tumor biopsy. The tumors were evaluated according to the 2010 WHO classification based on the number of mitoses and the Ki67 proliferation index. Adjuvant treatment was adapted according to staging and histopathological parameters. Despite recent progress in managing NETs, there are still many controversial aspects regarding the management of these cases, mainly about timing the right sequence of therapy.</abstract><cop>Romania</cop><pmid>31060657</pmid><doi>10.21614/chirurgia.114.2.243</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1221-9118
ispartof Chirurgia (Bucharest, Romania : 1990), 2019-03, Vol.114 (2), p.243-250
issn 1221-9118
language eng
recordid cdi_proquest_miscellaneous_2232136063
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
Aged
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Breast Neoplasms - diagnosis
Breast Neoplasms - therapy
Chemotherapy, Adjuvant
Digestive System Neoplasms - diagnosis
Digestive System Neoplasms - drug therapy
Digestive System Neoplasms - surgery
Digestive System Neoplasms - therapy
Disease Management
Female
Humans
Male
Middle Aged
Neuroendocrine Tumors - diagnosis
Neuroendocrine Tumors - drug therapy
Neuroendocrine Tumors - surgery
Neuroendocrine Tumors - therapy
Prognosis
Retroperitoneal Neoplasms - diagnosis
Retroperitoneal Neoplasms - therapy
Treatment Outcome
Uterine Neoplasms - diagnosis
Uterine Neoplasms - therapy
title Hindgut and Midgut Neuroendocrine Tumors - Therapeutic Approach
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T01%3A50%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hindgut%20and%20Midgut%20Neuroendocrine%20Tumors%20-%20Therapeutic%20Approach&rft.jtitle=Chirurgia%20(Bucharest,%20Romania%20:%201990)&rft.au=Gavrilescu,%20Mihaela%20M%C4%83d%C4%83lina&rft.date=2019-03-01&rft.volume=114&rft.issue=2&rft.spage=243&rft.epage=250&rft.pages=243-250&rft.issn=1221-9118&rft_id=info:doi/10.21614/chirurgia.114.2.243&rft_dat=%3Cproquest_cross%3E2232136063%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2232136063&rft_id=info:pmid/31060657&rfr_iscdi=true